Plain-English translation of NCT07189806 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The MAPLE study is a long-term research project that follows people with asthma—from very mild to severe—to understand why asthma affects different people differently. Researchers will collect information about your symptoms, breathing tests, and blood samples over at least five years to identify patterns that predict which patients are more likely to experience worsening asthma and what triggers those changes.
Asthma looks different in every patient, and doctors don't yet fully understand why some people stay stable while others get worse over time, or what causes flare-ups. This study aims to find predictive markers in blood and breathing patterns that could help doctors personalize asthma care and prevent disease progression.
You likely qualify if…
You likely don't qualify if…
You would visit the hVIVO clinic once per year for breathing tests, blood draws, and health assessments. Between visits, you would complete at-home self-monitoring using simple measurements (like peak flow readings). The study is designed to last at least five years, with no fixed end date, so researchers can track how your asthma changes and what factors influence those changes over a long period.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United Kingdom